Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Resource Center will be recognizing two outstanding community leaders who are “making an impact in the LGBTQIA+ community” ...

Research led by The University of Texas Health Science Center at San Antonio identifies a means of blocking recurrence of glioblastoma, the deadliest brain cancer.

Boston-based Suffolk said Evan McKee will draw on his proven track record to focus on expanding the company's portfolio ...

Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block ...

Childhood-onset striatonigral neurodegeneration robs children of the ability to walk and talk by age five. Researchers at ...

This day marks a turning point in their careers. The waiting, the interviews, the uncertainty — it all comes to a head here," ...

Suffolk, one of the largest and most innovative construction enterprises in the country, announced it hired Evan McKee as the ...

Clinical enrollment concludes for Spark Biomedical’s pivotal trial investigating a non-invasive, drug-free neurostimulation ...

Texas Women's Foundation presents Maura Awards for women helping women, leadership forum and young leaders award celebration ...